RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Clinical trials for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot targets tough blood cancers in early human trial
Disease control Recruiting nowThis early-stage study tests a new drug called QLS2309 in people with CD70-positive blood cancers that have returned or not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 186 adults will take …
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental drug trichostatin a tested for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing the safety of a drug called trichostatin A in adults whose blood cancers have returned or stopped responding to standard treatments. The main goal is to find a safe dose and understand side effects. About 42 participants will receive the drug and…
Matched conditions: RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Phase: PHASE1 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:53 UTC